Patent Assignment
Reel/Frame 040512/0162
Assignment of Assignor's Interest
Recorded: 2016-10-28
Pages: 9
Assignor
EUTHYMICS BIOSCIENCE, INC.
Executed: 2015-03-02
Assignee
NEUROVANCE, INC.
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(17)
Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
Application:
11/493,431 →
Publication:
US 2007/0082940
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
12/334,432 →
Publication:
US 2009/0233978
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation and Use to Treat Neuropsychiatric Disorders
Application:
13/207,199 →
Novel 1-aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
Application:
13/221,892 →
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
Application:
13/425,371 →
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
Application:
13/669,438 →
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods for Their Preparation and Their Use as Medicaments
Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
Application:
13/334,066 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/528,940 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/751,169 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/907,921 →
Publication:
US 2014/0206740
Novel Arylbicyclo[3.1.0]Hexylamines and Methods and Compositions for Their Preparation and Use
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2007
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019578/0394 →
Assignment of Assignor's Interest
Aug 19, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019713/0936 →
Assignment of Assignor's Interest
Nov 26, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING; YANG, JI
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 020150/0061 →
Assignment of Assignor's Interest
Dec 22, 2011
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027437/0683 →
Merger
Dec 29, 2011
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027457/0641 →
Formation and Reorganization Agreement
Dec 29, 2011
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 027464/0279 →
Merger
Dec 17, 2013
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 031801/0663 →
Assignment of Assignor's Interest
Dec 17, 2013
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031798/0398 →
Merger
Dec 17, 2013
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 031798/0450 →
Assignment of Assignor's Interest
Dec 17, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031798/0483 →
Assignment of Assignor's Interest
Dec 17, 2013
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031801/0414 →
Assignment of Assignor's Interest
Dec 17, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031801/0867 →
Corrective Assignment to Correct the State for Assignee Previously Recorded on Reel 031801 Frame 0867. Assignor(S) Hereby Confirms the Change from New Jersey to Massachusetts.
Dec 27, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031996/0881 →
Assignment of Assignor's Interest
Jan 10, 2014
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031945/0082 →
Assignment of Assignor's Interest
Jan 10, 2014
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031945/0115 →
Merger
Jan 10, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 031945/0119 →
Change of Name
Feb 20, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 032258/0937 →
Assignment of Assignor's Interest
Feb 20, 2014
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032258/0128 →
Assignment of Assignor's Interest
Feb 20, 2014
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 032260/0071 →
Assignment of Assignor's Interest
Jan 22, 2015
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 034791/0384 →
Assignment of Assignor's Interest
Jan 22, 2015
From: MCKINNEY, ANTHONY; BYMASTER, FRANK
To: NEUROVANCE, INC.
Reel/Frame 034791/0696 →
Assignment of Assignor's Interest
Jan 22, 2015
From: BYMASTER, FRANK; MCKINNEY, ANTHONY ALEXANDER
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 034791/0008 →
Assignment of Assignor's Interest
Jan 25, 2017
From: NEUROVANCE, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 041085/0177 →
Assignment of Assignor's Interest
Jan 26, 2017
From: NEUROVANCE, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 041098/0323 →
Assignment of Assignor's Interest
Nov 1, 2017
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 044349/0209 →